Sara T. Ibrahim

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease

Ibrahim Ali, Rajkumar Chinnadurai, Sara T. Ibrahim et al. · BMC Nephrology · 2020 · 38 citations · Full text

Medicine, Biostatistics, Nephrology +16

Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression

Ibrahim Ali, Rajkumar Chinnadurai, Sara T. Ibrahim et al. · BMC Nephrology · 2021 · 23 citations · Full text

Medicine, Internal Medicine, Nephrology +16

β-Cell pre-mir-21 induces dysfunction and loss of cellular identity by targeting transforming growth factor beta 2 (Tgfb2) and Smad family member 2 (Smad2) mRNAs

Sara T. Ibrahim, Macey Johnson, Clarissa Hernandez Stephens et al. · Molecular Metabolism · 2021 · 20 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17